Leukemia, Chronic Lymphatic Clinical Trial
Official title:
Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia (CLL)
Retrospective evaluation on the effect of splenic irradiation on clinical and hematological response and toxicity in patients with chronic lymphatic leukaemia (CLL).
The study will include patients with CLL treated with splenic irradiation in Maastro Clinic, Maastricht, The Netherlands, Maxima Medisch Centrum Veldhoven/Catharina hospital, Eindhoven, The Netherlands and Modena hospital, Modena, Italy. Data will be collected from patient records in an uniform database. Data will include demographic data, CLL stadium (RAI and Binet) at diagnosis and at the time of irradiation treatment, clinical data at diagnosis (haematology), splenic irradiation data, follow-up data such as date of progression or death ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03204188 -
Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
|
Phase 2 | |
| Completed |
NCT02802943 -
iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL
|
Phase 2 | |
| Recruiting |
NCT04407845 -
Atrial Fibrillation in Patients Receiving Ibrutinib
|